Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

The researchers are trying to evaluate a newer imaging technique (Ga-DOTATATE PET/CT) to see if it is more sensitive to localize the source of the hormone, which has caused the low phosphate

  • 0 views
  • 01 Jul, 2021
  • 1 location
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

limited and generally not effective. Researchers want to see if they can better detect thyroid tumors by using a compound called 68Gallium-DOTATATE. This compound may bind to a tumor and make it visible

  • 5 views
  • 28 Jun, 2022
  • 1 location
Targeted Therapy and Avelumab in Merkel Cell Carcinoma

10.17 GoTHAM is intended as a signal-seeking, biomarker, phase Ib/II study that will evaluate the safety and anti-tumour activities of the novel combination of avelumab with 177-Lu-DOTATATE (a

  • 0 views
  • 29 Apr, 2021
  • 6 locations
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

The purpose of this study is to learn about the feasibility and safety of using Peptide Receptor Radionuclide Therapy (PRRT) before and after surgical removal of a tumor. PRRT treatment is based on the administration of a radioactive product, 177-Lu DOTA-0-Tyr3-Octreotate (Lutathera®) and its use before and after surgery is …

  • 0 views
  • 28 Jun, 2022
  • 1 location
Dosimetry Using a CZT-camera Following LUTATHERA Therapy

The aim of this study is to assess the consistency between a dosimetry protocol using a large field of view CZT-camera and the dosimetry protocol used for recordings acquired with a conventional camera. Therefore, with the conventional camera, recordings are acquired on the "high energy" peak of lutetium 177 (208 …

  • 0 views
  • 13 Aug, 2021
  • 1 location
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors

This is a research study to collect information regarding usefulness of positron emission tomography (PET) scans using a special dye called 68Ga-DOTATATE for patients with neuroendocrine tumours

pet/ct scan
positron emission tomography
dotatate
conventional imaging
  • 0 views
  • 05 Dec, 2021
  • 1 location
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

study will assess the safety and diagnostic effectiveness of 68Ga-HA-DOTATATE produced a the Edmonton Radiopharmaceutical Centre (ERC).

  • 0 views
  • 03 May, 2022
  • 1 location
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

The LuDO-N Trial is a multi-centre phase II clinical trial on 177Lu-DOTATATE treatment of recurrent or relapsed high-risk neuroblastoma in children. The LuDO-N Trial builds on the experience

somatostatin
neutrophil count
68ga-dotatoc
high-risk neuroblastoma
  • 0 views
  • 05 Jun, 2021
  • 6 locations
Diagnosis of Pheochromocytoma

. Patients may undergo 18F-FDOPA, 18F-DA, as well as 68Ga-DOTATATE PET/CT . Each scan takes up to about 2 hours. Genetic testing - A small blood sample is collected for DNA analysis and other

iobenguane
dopamine
hypertension
catecholamines
clonidine
  • 20 views
  • 05 Jul, 2022
  • 1 location
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

people with VHL disease. Objective To better understand VHL disease that affects the pancreas and to test whether adding a certain type of scan (68-Gallium DOTATATE

neuroendocrine tumor
genetic testing
cyst
pet/ct scan
ct scan
  • 0 views
  • 05 Jul, 2022
  • 1 location